Yu, P.-C.; Huang, C.-H.; Kuo, C.-J.; Liang, P.-H.; Wang, L.H.-C.; Pan, M.Y.-C.; Chang, S.-Y.; Chao, T.-L.; Ieong, S.-M.; Fang, J.-T.;
et al. Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Pharmaceutics 2022, 14, 176.
https://doi.org/10.3390/pharmaceutics14010176
AMA Style
Yu P-C, Huang C-H, Kuo C-J, Liang P-H, Wang LH-C, Pan MY-C, Chang S-Y, Chao T-L, Ieong S-M, Fang J-T,
et al. Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Pharmaceutics. 2022; 14(1):176.
https://doi.org/10.3390/pharmaceutics14010176
Chicago/Turabian Style
Yu, Pei-Chen, Chen-Hao Huang, Chih-Jung Kuo, Po-Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan, Sui-Yuan Chang, Tai-Ling Chao, Si-Man Ieong, Jun-Tung Fang,
and et al. 2022. "Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets" Pharmaceutics 14, no. 1: 176.
https://doi.org/10.3390/pharmaceutics14010176
APA Style
Yu, P.-C., Huang, C.-H., Kuo, C.-J., Liang, P.-H., Wang, L. H.-C., Pan, M. Y.-C., Chang, S.-Y., Chao, T.-L., Ieong, S.-M., Fang, J.-T., Huang, H.-C., & Juan, H.-F.
(2022). Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Pharmaceutics, 14(1), 176.
https://doi.org/10.3390/pharmaceutics14010176